Show Only:
  • Dealmaker

    The Top 20 Co-investing LPs

    Privcap shines a light on the LPs with the strongest appetite for direct and co-investment

    May 13, 2014
    More
  • Dealmaker

    The New Era of Co-invest

    Sophisticated investors want more private equity, but on their own terms. How are GPs managing the transition?

    May 13, 2014
    More
  • Dealmaker

    Finding the Right Co-investment Partner

    Tom Haubenstricker of GoldPoint Partners discusses the firm’s evolution from in-house investor for New York Life to a standalone co-investment powerhouse.

    May 13, 2014
    More
  • Dealmaker

    Case Studies: Separate Accounts

    The effectiveness of separate accounts has been in question as LPs have taken up the practice, with some value when structured appropriately.

    May 13, 2014
    More
  • Dealmaker

    The Research on Returns

    Empirical research into the role of co-investing in an institutional portfolio is scarce. Here are summaries of three important projects to date.

    May 13, 2014
    More
  • Dealmaker

    Fee Breaks, Deconstructed

    As more LPs jump on the co-investing bandwagon, the question arises: how do you quantify the benefit of direct investments for an LP’s private equity portfolio?

    May 13, 2014
    More
  • Dealmaker

    Allocation Policies

    Not all firms abide by a co-investment allocation policy. And those that do have distinct ways of determining allocations. We look at how various models work, which ones offer the best terms for LPs, and policy gray areas.

    May 13, 2014
    More
  • Dealmaker

    Deal Success & Family-Owned Businesses in Colombia

    A successful exit of a Colombian healthcare company; why doing deals with families can be challenging.

    May 12, 2014
    More
  • Nitin Gupta
    Dealmaker

    Caspian’s Dedication to Co-investment

    Nitin Gupta of Caspian Private Equity discusses the appetite for co-investments and the components and practices that go into running this type of dedicated fund.

    May 1, 2014
    More
  • Paul Levy
    Dealmaker

    JLL’s $2.65B Turnaround Story

    JLL Partners’ Paul Levy on how his firm bought the struggling pharmaceutical manufacturing groups Patheon and turned it around. JLL then executed a $2.65b merger with Royal DSM to form DPx.

    April 8, 2014
    More
  • Mike Liang
    Dealmaker

    Devices of Value: Baird Capital Backs Insightra Medical

    Baird Capital’s Mike Liang describes his firm’s investment in Insightra Medical.

    February 26, 2014
    More
  • Dealmaker

    Managing Music: KKR’s Investment in BMG

    Philipp Freise of KKR shares details about the highly successful investment in music-rights management business BMG.

    February 5, 2014
    More
  • Dealmaker

    The Craft of the Carve-Out

    An executive summary of the Privcap series Carve-Outs: The Art & Science of Dealmaking.

    February 3, 2014
    More
  • Dealmaker

    Top Private Equity Tax Trends

    An executive summary of the Privcap series Taxes and Liabilities in Private Equity.

    January 20, 2014
    More
  • Dealmaker

    Arsenal and Chromaflo: Adding Value

    Experts discuss the challenges of integrating a company into a portfolio and how leaders from the portfolio and parent companies communicate with each other.

    January 19, 2014
    More
  • Ben Marzouk
    Dealmaker

    Debt Outlook for 2014

    Two industry lending veterans, Ben Marzouk of Monroe Capital and Joe Burkhart of Saratoga Investment, predict what’s to come for debt markets in 2014.

    January 15, 2014
    More
  • Dealmaker

    Supply-Chain Gains: How Greenbriar Partnered with GENCO

    Transportation-focused private equity firm Greenbriar and its investment in logistics company GENCO.

    December 27, 2013
    More
  • Dealmaker

    Exploring Exits in African Private Equity

    New research explores the issues of value creation and exits in African PE.

    December 27, 2013
    More